{
    "root": "2f21523c-2997-dc4c-e063-6394a90a6229",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ATORVASTATIN CALCIUM",
    "value": "20250227",
    "ingredients": [
        {
            "name": "CALCIUM CARBONATE",
            "code": "H0G9379FGK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3311"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (110000 WAMW)",
            "code": "5Y0974F5PW",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00840"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 101",
            "code": "7T9FYH5QMK",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 102",
            "code": "PNR0YF693Y",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "ATORVASTATIN CALCIUM TRIHYDRATE",
            "code": "48A5M73Z4Q",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_2911"
        }
    ],
    "indications": {
        "text": "atorvastatin calcium tablets indicated : \u2022 reduce risk : myocardial infarction ( myocardial infarction ) , stroke , revascularization procedures , angina adults multiple risk factors coronary heart disease ( chd ) without clinically evident chd myocardial infarction stroke adults type 2 diabetes mellitus multiple risk factors chd without clinically evident chd non-fatal myocardial infarction , fatal non-fatal stroke , revascularization procedures , hospitalization congestive heart failure , angina adults clinically evident chd \u2022 adjunct diet reduce low-density lipoprotein cholesterol ( ldl-c ) : adults primary hyperlipidemia . adults pediatric patients aged 10 years older heterozygous familial hypercholesterolemia ( hefh ) . \u2022 adjunct ldl-c-lowering therapies , alone treatments unavailable , reduce ldl-c adults pediatric patients aged 10 years older homozygous familial hypercholesterolemia ( hofh ) . \u2022 adjunct diet treatment adults : primary dysbetalipoproteinemia hypertriglyceridemia",
        "doid_entities": [
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            },
            {
                "text": "stroke (DOID:6713)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6713"
            },
            {
                "text": "coronary heart disease (DOID:3393)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3393"
            },
            {
                "text": "heart disease (DOID:114)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_114"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "type 2 diabetes mellitus (DOID:9352)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9352"
            },
            {
                "text": "diabetes (DOID:9351)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9351"
            },
            {
                "text": "congestive heart failure (DOID:6000)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6000"
            },
            {
                "text": "familial hypercholesterolemia (DOID:13810)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13810"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "\u2022 take orally daily without food ( 2.1 ) . \u2022 assess ldl-c clinically appropriate , early 4 weeks initiating atorvastatin calcium tablets , adjust necessary ( 2.1 ) . \u2022 adults ( 2.2 ) : recommended starting 10 20 mg daily ; range 10 mg 80 mg daily . patients requiring ldl-c reduction > 45 % may start 40 mg daily . \u2022 pediatric patients aged 10 years age older hefh : recommended starting 10 mg daily ; range 10 20 mg daily ( 2.3 ) . \u2022 pediatric patients aged 10 years age older hofh : recommended starting 10 20 mg daily ; range 10 80 mg daily ( 2.4 ) . \u2022 full prescribing information atorvastatin calcium tablets modifications due ( 2.5 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "atorvastatin calcium tablets , usp supplied follows : strength supplied ndc tablet description 10 mg atorvastatin bottles 90 ndc 31722-424-90 white off-white , oval , biconvex film coated tablets debossed '10 ' one side ' 53 ' side bottles 500 ndc 31722-424-05 bottles 1000 ndc 31722-424-10 20 mg atorvastatin bottles 90 ndc 31722-425-90 white off-white , oval , biconvex film coated tablets debossed '20 ' one side ' 54 ' side bottles 500 ndc 31722-425-05 bottles 1000 ndc 31722-425-10 40 mg atorvastatin bottles 90 ndc 31722-426-90 white off-white , oval , biconvex film coated tablets debossed '40 ' one side ' 55 ' side bottles 500 ndc 31722-426-05 bottles 1000 ndc 31722-426-10 80 mg atorvastatin bottles 90 ndc 31722-427-90 white off-white , oval , biconvex film coated tablets debossed '80 ' one side ' 56 ' side bottles 500 ndc 31722-427-05 bottles 1000 ndc 31722-427-10 storage store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "\u2022 acute liver failure decompensated cirrhosis [ ( 5.3 ) ] \u2022 hypersensitivity atorvastatin excipients atorvastatin calcium . hypersensitivity , including anaphylaxis , angioneurotic edema , erythema multiforme , stevens-johnson syndrome , toxic epidermal necrolysis , reported [ ( 6.2 ) ] .",
    "indications_original": "Atorvastatin calcium tablets\u00a0 are indicated:\u00a0 \n    \u2022 To reduce the risk of:\u00a0 \n    o Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with \n    \u00a0 \u00a0 \u00a0multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD\u00a0 \n    o MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD\u00a0 but without clinically evident CHD\u00a0 \n    o Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for\u00a0 \n    \u00a0 \u00a0 \u00a0congestive heart failure, and angina in adults with clinically evident CHD\u00a0 \n    \u2022 As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in:\u00a0 \n    o Adults with primary hyperlipidemia.\u00a0 \n    o Adults and pediatric patients aged 10 years and older with heterozygous familial\u00a0 \u00a0 \u00a0 hypercholesterolemia (HeFH).\u00a0 \n    \u2022 As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH).\u00a0 \n    \u2022 As an adjunct to diet for the treatment of adults with:\u00a0 \n    o Primary dysbetalipoproteinemia\u00a0 \n    o Hypertriglyceridemia",
    "contraindications_original": "\u2022 Take orally once daily with or without food ( 2.1 ). \u2022 Assess LDL-C when clinically appropriate, as early as 4 weeks after initiating atorvastatin calcium tablets, and adjust dosage if necessary ( 2.1 ). \u2022 Adults ( 2.2 ): o Recommended starting dosage is 10 or 20 mg once daily; dosage range is 10 mg to 80 mg once daily. o Patients requiring LDL-C reduction >45% may start at 40 mg once daily. \u2022 Pediatric Patients Aged 10 Years of Age and Older with HeFH: Recommended starting dosage is 10 mg once daily; dosage range is 10 to 20 mg once daily ( 2.3 ). \u2022 Pediatric Patients Aged 10 Years of Age and Older with HoFH: Recommended starting dosage is 10 to 20 mg once daily; dosage range is 10 to 80 mg once daily ( 2.4 ). \u2022 See full prescribing information for atorvastatin calcium tablets dosage modifications due to drug interactions ( 2.5 ).",
    "warningsAndPrecautions_original": "Atorvastatin Calcium Tablets, USP are supplied as follows:\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              Strength\n                              \n                           \n                           \n                              How Supplied\n                              \n                           \n                           \n                              NDC\n                              \n                           \n                           \n                              Tablet Description\n                              \n                           \n                        \n                        \n                           10 mg of atorvastatin \n       \u00a0 \n     \n                           \n                           bottles of 90 \n     \n                           \n                           NDC 31722-424-90 \n     \n                           \n                           white to off-white, oval, biconvex film coated tablets debossed with '10' on one side and 'A 53' on other side \n     \n                           \n                        \n                        \n                           bottles of 500 \n     \n                           \n                           NDC 31722-424-05 \n     \n                           \n                        \n                        \n                           bottles of 1000 \n     \n                           \n                           NDC 31722-424-10 \n     \n                           \n                        \n                        \n                           20 mg of atorvastatin \n       \u00a0 \n     \n                           \n                           bottles of 90 \n     \n                           \n                           NDC 31722-425-90 \n     \n                           \n                           white to off-white, oval, biconvex film coated tablets debossed with '20' on one side and 'A 54' on other side \n     \n                           \n                        \n                        \n                           bottles of 500 \n     \n                           \n                           NDC 31722-425-05 \n     \n                           \n                        \n                        \n                           bottles of 1000 \n     \n                           \n                           NDC 31722-425-10 \n     \n                           \n                        \n                        \n                           40 mg of atorvastatin \n       \u00a0 \n     \n                           \n                           bottles of 90 \n     \n                           \n                           NDC 31722-426-90 \n     \n                           \n                           white to off-white, oval, biconvex film coated tablets debossed with '40' on one side and 'A 55' on other side \n     \n                           \n                        \n                        \n                           bottles of 500 \n     \n                           \n                           NDC 31722-426-05 \n     \n                           \n                        \n                        \n                           bottles of 1000 \n     \n                           \n                           NDC 31722-426-10 \n     \n                           \n                        \n                        \n                           80 mg of atorvastatin \n       \u00a0 \n     \n                           \n                           bottles of 90 \n     \n                           \n                           NDC 31722-427-90 \n     \n                           \n                           white to off-white, oval, biconvex film coated tablets debossed with '80' on one side and 'A 56' on other side \n     \n                           \n                        \n                        \n                           bottles of 500 \n     \n                           \n                           NDC 31722-427-05 \n     \n                           \n                        \n                        \n                           bottles of 1000 \n     \n                           \n                           NDC 31722-427-10 \n     \n                           \n                        \n                     \n                  \n                  \n                  \n                     Storage\n                     \n                       Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "\u2022 Acute liver failure or decompensated cirrhosis\n \n  [see\n  \n   Warnings and Precautions (5.3)]\u00a0\n \n  \n                       \u2022 Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium. Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported\n \n  [see\n  \n   Adverse Reactions (6.2)]\n \n  .",
    "drug": [
        {
            "name": "ATORVASTATIN CALCIUM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50686"
        }
    ]
}